-
FDA approves Gilead Sciences’ Biktarvy label update for pregnant adults with HIV
The updated label with additional data reinforces the safety and efficacy profile of Biktarvy to treat pregnant people with HIV-1 with suppressed viral loads, the company said. -
Avenacy debuts generic Integrilin for Injection
Eptifibatide for Injection is indicated for use in acute coronary syndrome and percutaneous coronary intervention.